Biotech

All Articles

FDA junks adcomm for Applied's uncommon illness medication

.After dismissing the decision date for Applied Therapies' metabolic ailment drug govorestat, the FD...

Novo inks $600M NanoVation offer to research hereditary medications ex-liver

.Novo Nordisk is continuing its own push in to hereditary medications, accepting pay NanoVation Ther...

Innovent hyperlinks cytokine to colorectal cancer actions

.Innovent Biologics has actually made the case that its gate inhibitor-cytokine blend protein has a ...

Merck, Daiichi ADC hits objective in period 3 lung cancer research study

.A stage 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina deepens AI focus with collab to choose cancer cells targets

.Five months after Rakovina Therapies rotated towards expert system, the cancer-focused biotech has ...

Ascendis' dwarfism drug hits in period 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a prospective threat to BioMarin's Voxzogo, disclosing peri...

Despite ph. 3 skip, Alkeus finds pathway in advance for eye health condition possession

.Though Alkeus Pharmaceuticals' dental eye disease resource stopped working to significantly lower g...

Kairos goes public along with $6M IPO to fund trials of cancer cells medication

.Along with a triad of biotechs attacking the Nasdaq on Friday, it was easy to miss a smaller-scale ...

Vaccine and Keytruda combo reliable in squamous tissue cancer

.Immune gate inhibitors are actually the superheroes of cancer therapy. Medicines like Bristol Myers...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings ...